Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-11
2006-04-11
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S254010, C544S374000, C544S388000, C544S383000, C544S387000, C544S393000, C544S400000
Reexamination Certificate
active
07026323
ABSTRACT:
Compounds of the following formula (I):where a, b, R1, R2, R3, R4and R6are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.
REFERENCES:
patent: 4258192 (1981-03-01), Okamoto et al.
patent: 5346907 (1994-09-01), Kerwin, Jr. et al.
patent: 5607937 (1997-03-01), Stuerzebecher et al.
patent: 739 886 (1996-10-01), None
patent: 1334705 (1973-10-01), None
patent: WO 92/08709 (1992-05-01), None
patent: WO 94/18185 (1994-08-01), None
patent: WO 98/56771 (1998-12-01), None
CAS Registry Numbers, p. 1-18 obtained from Com Genex Product List , published Jun. 26, 2003.
ComGenex Product List (2001), Supplementary information concerning Ten Products available for sale.
Dullweber, F. et al., “Factorising Ligand Affinity: A Combined Thermodynamic and Crystallographic Study of Trypsin and Thrombin Inhibition,”J. Mol. Biol. 313: 593-614, 2001.
Folts et al., “Platelet Aggregation in Partially Obstructed Vessels and its Elimination with Aspirin,”Circulation 54(3):365-370, 1976.
Gachet et al., “Purinoceptors on Blood Platelets: Further Pharmacological and Clinical Evidence to Suggest the Presence of Two ADP Receptors,”British Journal Haematology 91(2):434-444, Oct. 1995.
Herbert et al., “Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent,”Cardiovascular Drug Reviews 11(2):180-198, 1993.
Humphries et al., “Pharmacological Profile of the Novel P2T-Purinoceptor Antagonist, FPL 67085 in vitro and in the Anaesthetized Rat in vivo,”British Journal of Pharmacology 115(6):1110-1116, Jul. 1995.
Kamm, W. et al., “Transport of Peptidomimetic Thrombin Inhibitors with a 3-Amidino-Phenylalnine Structure: Permeability and Efflux Mechanism in Monolayers of a Human Intestinal Cell Line (Caco-2),”Pharmaceutical Research 18(8): 1110-1118, 2001.
Kaslow and Marsh, “Substituted Bromoquinolines” J. Organic Chemistry 12(3):456-458, May 1947.
Mills, “ADP Receptors on Platelets,”Thrombosis Haemostasis 76(6):835-856, Dec. 1996.
Mustard, et al., “Isolation of Human Platelets from Plasma by Centrifugation and Washing,”Methods Enzymology 169:3-11, 1989.
Pierce, A.C. and Jorgenson, W.L., “Estimation of Binding Affinities for Selective Thrombin Inhibitors via Monte Carlo Simulations,”J. Med. Chem. 44: 1043-1050, 2001.
Späth, “Zur Konstitution der Kyurensäure,”Monatshefte für Chimie 42:89-95, 1921.
Bryant Judi A.
Buckman Brad O.
Islam Imadul
Mohan Raju
Morrissey Michael M.
Bernhardt Emily
Schering Aktiengesellschaft
Seed IP Law Group PLLC
LandOfFree
Platelet adenosine diphosphate receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet adenosine diphosphate receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet adenosine diphosphate receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3590178